[1]
Lee BL,Bathija R,Weinreb RN, The definition of normal-tension glaucoma. Journal of glaucoma. 1998 Dec;
[PubMed PMID: 9871857]
[2]
The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. American journal of ophthalmology. 1998 Oct;
[PubMed PMID: 9780094]
[3]
Heijl A,Leske MC,Bengtsson B,Hyman L,Bengtsson B,Hussein M,Early Manifest Glaucoma Trial Group., Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of ophthalmology (Chicago, Ill. : 1960). 2002 Oct;
[PubMed PMID: 12365904]
[4]
Adeghate J,Rahmatnejad K,Waisbourd M,Katz LJ, Intraocular pressure-independent management of normal tension glaucoma. Survey of ophthalmology. 2019 Jan - Feb;
[PubMed PMID: 30300625]
Level 3 (low-level) evidence
[6]
Killer HE,Pircher A, Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye (London, England). 2018 May;
[PubMed PMID: 29456252]
Level 3 (low-level) evidence
[7]
Drance S,Anderson DR,Schulzer M,Collaborative Normal-Tension Glaucoma Study Group., Risk factors for progression of visual field abnormalities in normal-tension glaucoma. American journal of ophthalmology. 2001 Jun;
[PubMed PMID: 11384564]
[8]
Chen YY,Lai YJ,Yen YF,Shen YC,Wang CY,Liang CY,Lin KH,Fan LW, Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan. BMJ open. 2018 Nov 5;
[PubMed PMID: 30397009]
[9]
Chen MJ, Normal tension glaucoma in Asia: Epidemiology, pathogenesis, diagnosis, and management. Taiwan journal of ophthalmology. 2020 Oct-Dec;
[PubMed PMID: 33437596]
[10]
Shiose Y,Kitazawa Y,Tsukahara S,Akamatsu T,Mizokami K,Futa R,Katsushima H,Kosaki H, Epidemiology of glaucoma in Japan--a nationwide glaucoma survey. Japanese journal of ophthalmology. 1991;
[PubMed PMID: 1779484]
Level 3 (low-level) evidence
[11]
Klein BE,Klein R,Sponsel WE,Franke T,Cantor LB,Martone J,Menage MJ, Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992 Oct;
[PubMed PMID: 1454314]
[12]
Dielemans I,Vingerling JR,Wolfs RC,Hofman A,Grobbee DE,de Jong PT, The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994 Nov;
[PubMed PMID: 7800368]
[13]
Rotchford AP,Johnson GJ, Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Archives of ophthalmology (Chicago, Ill. : 1960). 2002 Apr;
[PubMed PMID: 11934321]
Level 2 (mid-level) evidence
[14]
Mason RP,Kosoko O,Wilson MR,Martone JF,Cowan CL Jr,Gear JC,Ross-Degnan D, National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology. 1989 Sep;
[PubMed PMID: 2789357]
Level 3 (low-level) evidence
[15]
Colton T,Ederer F, The distribution of intraocular pressures in the general population. Survey of ophthalmology. 1980 Nov-Dec;
[PubMed PMID: 7466591]
Level 3 (low-level) evidence
[16]
Tomita G, The optic nerve head in normal-tension glaucoma. Current opinion in ophthalmology. 2000 Apr;
[PubMed PMID: 10848217]
Level 3 (low-level) evidence
[17]
Kosior-Jarecka E,Wróbel-Dudzińska D,Łukasik U,Żarnowski T, Ocular and Systemic Risk Factors of Different Morphologies of Scotoma in Patients with Normal-Tension Glaucoma. Journal of ophthalmology. 2017;
[PubMed PMID: 28815087]
[18]
Kottler MS,Drance SM, Studies of hemorrhage on the optic disc. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 1976 Apr;
[PubMed PMID: 1078325]
[20]
Lawlor M,Quartilho A,Bunce C,Nathwani N,Dowse E,Kamal D,Gazzard G, Patients With Normal Tension Glaucoma Have Relative Sparing of the Relative Afferent Pupillary Defect Compared to Those With Open Angle Glaucoma and Elevated Intraocular Pressure. Investigative ophthalmology
[PubMed PMID: 29049724]
[21]
Spaeth GL,Henderer J,Liu C,Kesen M,Altangerel U,Bayer A,Katz LJ,Myers J,Rhee D,Steinmann W, The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Transactions of the American Ophthalmological Society. 2002;
[PubMed PMID: 12545692]
[23]
Jampel HD,Singh K,Lin SC,Chen TC,Francis BA,Hodapp E,Samples JR,Smith SD, Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2011 May;
[PubMed PMID: 21539982]
[24]
Garway-Heath DF,Zhu H,Cheng Q,Morgan K,Frost C,Crabb DP,Ho TA,Agiomyrgiannakis Y, Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study. Health technology assessment (Winchester, England). 2018 Jan;
[PubMed PMID: 29384083]
[25]
Bussel II,Wollstein G,Schuman JS, OCT for glaucoma diagnosis, screening and detection of glaucoma progression. The British journal of ophthalmology. 2014 Jul;
[PubMed PMID: 24357497]
[26]
Ventura AC,Böhnke M,Mojon DS, Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension. The British journal of ophthalmology. 2001 Jul;
[PubMed PMID: 11423450]
[27]
Deol M,Taylor DA,Radcliffe NM, Corneal hysteresis and its relevance to glaucoma. Current opinion in ophthalmology. 2015 Mar;
[PubMed PMID: 25611166]
Level 3 (low-level) evidence
[28]
Bhartiya S,Gangwani M,Kalra RB,Aggarwal A,Gagrani M,Sirish KN, 24-hour Intraocular pressure monitoring: the way ahead. Romanian journal of ophthalmology. 2019 Oct-Dec;
[PubMed PMID: 31915728]
[29]
Sakata R,Aihara M,Murata H,Saito H,Iwase A,Yasuda N,Araie M, Intraocular pressure change over a habitual 24-hour period after changing posture or drinking water and related factors in normal tension glaucoma. Investigative ophthalmology
[PubMed PMID: 23821194]
[30]
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. American journal of ophthalmology. 1998 Oct;
[PubMed PMID: 9780093]
[31]
Higashide T,Ohkubo S,Udagawa S,Sugiyama K,Tanihara H,Araie M,Tomita G,Matsumoto C,Fukuchi T,Tomidokoro A,Hangai M,Kawata H,Inai M,Tanaka Y,SVF Prospector Study Group., Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study. Ophthalmology. Glaucoma. 2020 Aug 21;
[PubMed PMID: 32835837]
[32]
Jeoung JW,Park KH,Kim JM,Kang SH,Kang JH,Kim TW,Kim DM, Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes. Ophthalmology. 2008 Dec;
[PubMed PMID: 19041474]
[33]
Krupin T,Liebmann JM,Greenfield DS,Ritch R,Gardiner S,Low-Pressure Glaucoma Study Group., A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. American journal of ophthalmology. 2011 Apr;
[PubMed PMID: 21257146]
Level 1 (high-level) evidence
[34]
Mataki N,Murata H,Sawada A,Yamamoto T,Shigeeda T,Araie M, Visual Field Progressive Rate in Normal Tension Glaucoma Before and After Trabeculectomy: A Subfield-Based Analysis. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2014 Sep-Oct;
[PubMed PMID: 26107911]
[35]
Iverson SM,Schultz SK,Shi W,Feuer WJ,Greenfield DS, Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma. Journal of glaucoma. 2016 May;
[PubMed PMID: 25719235]
[36]
Graham SL,Drance SM, Nocturnal hypotension: role in glaucoma progression. Survey of ophthalmology. 1999 Jun;
[PubMed PMID: 10416743]
Level 3 (low-level) evidence
[37]
Cimaglia G,Votruba M,Morgan JE,André H,Williams PA, Potential Therapeutic Benefit of NAD{sup} {/sup} Supplementation for Glaucoma and Age-Related Macular Degeneration. Nutrients. 2020 Sep 19;
[PubMed PMID: 32961812]
[38]
Labkovich M,Jacobs EB,Bhargava S,Pasquale LR,Ritch R, Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2020 May-Jun;
[PubMed PMID: 32282348]
[39]
Cesareo M,Giannini C,Martucci A,Di Marino M,Pocobelli G,Aiello F,Mancino R,Nucci C, Links between obstructive sleep apnea and glaucoma neurodegeneration. Progress in brain research. 2020;
[PubMed PMID: 32988471]
[40]
Hecht I,Achiron A,Man V,Burgansky-Eliash Z, Modifiable factors in the management of glaucoma: a systematic review of current evidence. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2017 Apr;
[PubMed PMID: 27743157]
Level 1 (high-level) evidence
[41]
Tseng VL,Yu F,Coleman AL, Association between Exercise Intensity and Glaucoma in the National Health and Nutrition Examination Survey. Ophthalmology. Glaucoma. 2020 Sep - Oct;
[PubMed PMID: 32741639]
Level 3 (low-level) evidence
[42]
Cramer H,Krucoff C,Dobos G, Adverse events associated with yoga: a systematic review of published case reports and case series. PloS one. 2013;
[PubMed PMID: 24146758]
Level 2 (mid-level) evidence
[43]
Dada T,Mittal D,Mohanty K,Faiq MA,Bhat MA,Yadav RK,Sihota R,Sidhu T,Velpandian T,Kalaivani M,Pandey RM,Gao Y,Sabel BA,Dada R, Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. Journal of glaucoma. 2018 Dec;
[PubMed PMID: 30256277]
Level 1 (high-level) evidence
[44]
Dada T,Bhai N,Midha N,Shakrawal J,Kumar M,Chaurasia P,Gupta S,Angmo D,Yadav R,Dada R,Sihota R, Effect of Mindfulness Meditation on Intraocular Pressure and Trabecular Meshwork Gene Expression: A Randomized Controlled Trial. American journal of ophthalmology. 2021 Mar;
[PubMed PMID: 33393484]
Level 1 (high-level) evidence
[45]
Wang MTM,Danesh-Meyer HV, Cannabinoids and the eye. Survey of ophthalmology. 2021 Mar-Apr;
[PubMed PMID: 32763339]
Level 3 (low-level) evidence
[46]
Law SM,Lu X,Yu F,Tseng V,Law SK,Coleman AL, Cigarette smoking and glaucoma in the United States population. Eye (London, England). 2018 Apr;
[PubMed PMID: 29303150]
[47]
Baek SU,Ha A,Kim DW,Jeoung JW,Park KH,Kim YK, Risk factors for disease progression in low-teens normal-tension glaucoma. The British journal of ophthalmology. 2020 Jan;
[PubMed PMID: 31055450]
[48]
Prata TS,De Moraes CG,Teng CC,Tello C,Ritch R,Liebmann JM, Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage. Ophthalmology. 2010 Jan;
[PubMed PMID: 19896197]
[50]
Azoulay-Sebban L,Zhao Z,Zenouda A,Lombardi M,Gutman E,Brasnu E,Hamard P,Sahel JA,Baudouin C,Labbé A, Correlations Between Subjective Evaluation of Quality of Life, Visual Field Loss, and Performance in Simulated Activities of Daily Living in Glaucoma Patients. Journal of glaucoma. 2020 Oct;
[PubMed PMID: 32649451]
Level 2 (mid-level) evidence
[51]
Montana CL,Bhorade AM, Glaucoma and quality of life: fall and driving risk. Current opinion in ophthalmology. 2018 Mar;
[PubMed PMID: 29266021]
Level 2 (mid-level) evidence
[52]
Ramulu PY,Mihailovic A,West SK,Gitlin LN,Friedman DS, Predictors of Falls per Step and Falls per Year At and Away From Home in Glaucoma. American journal of ophthalmology. 2019 Apr;
[PubMed PMID: 30639366]
[53]
Chow-Wing-Bom H,Dekker TM,Jones PR, The worse eye revisited: Evaluating the impact of asymmetric peripheral vision loss on everyday function. Vision research. 2020 Apr;
[PubMed PMID: 32179339]
[54]
Bhorade AM,Yom VH,Barco P,Wilson B,Gordon M,Carr D, On-road Driving Performance of Patients With Bilateral Moderate and Advanced Glaucoma. American journal of ophthalmology. 2016 Jun;
[PubMed PMID: 26949136]
[55]
Bro T,Andersson J, The effects of visual field loss from glaucoma on performance in a driving simulator. Acta ophthalmologica. 2021 Feb 2;
[PubMed PMID: 33529454]
[56]
Kucukevcilioglu M,Bayer A,Uysal Y,Altinsoy HI, Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clinical
[PubMed PMID: 23844550]
[57]
Sakata R,Shirato S,Miyata K,Aihara M, Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost. Japanese journal of ophthalmology. 2013 Mar;
[PubMed PMID: 23233196]
[58]
Quaranta L,Riva I,Gerardi C,Oddone F,Floriani I,Konstas AG, Quality of Life in Glaucoma: A Review of the Literature. Advances in therapy. 2016 Jun;
[PubMed PMID: 27138604]
Level 2 (mid-level) evidence
[59]
GBD 2019 Blindness and Vision Impairment Collaborators.,Vision Loss Expert Group of the Global Burden of Disease Study., Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet. Global health. 2021 Feb;
[PubMed PMID: 33275949]
[60]
Stein JD,Khawaja AP,Weizer JS, Glaucoma in Adults-Screening, Diagnosis, and Management: A Review. JAMA. 2021 Jan 12;
[PubMed PMID: 33433580]